Physician profile
Michael J Pro
NPI 1639137524
$35,271.90
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,157 · 2020: $1,457 · 2021: $282 · 2022: $579 · 2023: $1,278 · 2024: $13K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Consulting Fee: $11K · Food and Beverage: $4,170 · Travel and Lodging: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $13,500.00 |
| Consulting Fee | $10,825.00 |
| Food and Beverage | $4,170.10 |
| Travel and Lodging | $1,302.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $18,732.48 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Alcon Vision LLC | $12,093.97 | 2020-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Glaukos Corporation | $1,502.58 | 2019-2025 | Idosetr, Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $1,417.35 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $348.39 | 2019-2021 | |
| Abbvie INC. | $286.40 | 2022-2025 | |
| Ivantis, INC | $257.87 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $205.85 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $108.63 | 2019-2021 | |
| Ellexiscience | $106.39 | 2019 | |
| Bausch & Lomb Americas INC. | $68.38 | 2023-2024 | Vyzulta, Envista Mx60 Iol, Xiidra |
| Dompe US, INC. | $34.31 | 2023 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $29.81 | 2019 | |
| Biotissue Holdings INC. | $22.71 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $14.24 | 2019 | |
| Eyevance Pharmaceuticals LLC | $12.73 | 2022 | |
| Mallinckrodt Hospital Products INC. | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.